Benefits – OrthoDx

Synvichor sets a new global medical standard that enhances surgeon’s treatment options, improves outcomes for patients, and reduces the burden on the hospital system.

Synvichor has been designed to fit into your existing testing and work-up routine for all patients with undifferentiated joint pain.

Synvichor has the potential to deliver billion-dollar savings to the healthcare system annually and significantly increase hospital bed day capacity per year.

Enhances surgeons’ treatment decisions

Rapid and accurate diagnosis, without any additional effort to the existing testing and work-up routine for undifferentiated joint pain
Faster differentiation of joint pain
Reduces overtreatment with antibiotics
Optimises clinical and patient outcomes
Increases confidence to initiate optimal treatment plan

Get in touch

Improves patient outcomes

Rapid and accurate diagnosis provides patients clarity about their condition and confidence in their treatment
Optimises clinical and quality of life outcomes
Reduces risk of complications
Reduces overuse of antibiotics and avoids over/under treatment
Patients get home faster

Find out more

Reduces the burden on hospitals

Up to 65% fewer admissions for non-infectious patients
Potential to increase hospital capacity by over 100,000 bed days per year
Potential to reduce average length of stay for infections
Ability to increase elective surgery procedures
Allows hospitals to receive correct reimbursement for patient care, adding ~$700m in revenue for an additional 25,000 patients.

Discover how

“The pathway from rapid differentiation of

pathology to the best treatment and outcome

has been streamlined.”

Dr Antony Rapisarda – CEO, OrthoDx

“The pathway from rapid

differentiation of pathology

to the best treatment and

outcome has been

streamlined.”